Skip to main content

Table 2 Global statistics on survival related variables for the datasets available in PROGmiR

From: PROGmiR: a tool for identifying prognostic miRNA biomarkers in multiple cancers using publicly available data

     Survival event No event
  Cancer type Dataset Total no of samples No of samples Median survival§(range) No of samples Median survival§*(range)
1 Adrenocortial Carcinoma GSE22816 22 6 600 (120-4860) 16 885 (60-4980)
2 Acute Myeloid Leukemia LAML 164 100 303 (28-1706) 64 699 (28-2861)
3 Brain Lower Grade Glioma LGG 29 23 788 (96-1915) 6 1317 (242-6423)
4 Glioblastoma multiforme GBM 487 383 377 (3-3880) 104 266 (3-2817)
5 Breast Invasive Carcinoma BRCA 727 91 1563 (157-4456) 636 466 (1-6795)
6 Non-small-cell Lung Cancer GSE16025 60 26 1980 (210-2490) 34 1500 (120-2580)
7 Small Cell Lung Cancer GSE27435 42 18 743 (234-2400) 24 1314 (426 -2490)
8 Lung Adenocarcinoma LUAD 79 27 701 (22-1318) 52 400 (1-2161)
9 Lung Squamous Cell Carcinoma LUSC 185 77 544 (12-5296) 108 640 (3-4299)
10 Hepatocellular Carcinoma GSE31384 166 73 450 (30 – 2280) 93 1320 (420-2430)
11 Head and Neck Squamous Cell Carcinoma HNSC 89 27 395 (128 – 2318) 62 359 (45 – 4115)
12 Ovarian Cystadenocarcinoma OV 46 21 887 (9-1756) 25 912 (141 – 2099)
13 Rectal Adenocarcinoma READ 38 3 316 (59 – 1184) 35 183 (28 – 2192)
14 Renal Clear Cell Carcinoma KIRC 546 173 722 (2-2830) 373 1307 (4 – 3377)
15 Stomach Adenocarcinoma STAD 79 14 258 (19 – 881) 65 109 (2 – 2131)
16 Uterine Corpus Endometroid Carcinoma UCEC 358 27 413 (58 – 3251) 331 527 (1 – 5690)
  1. § in days.
  2. * Follow up time.